Inari is poised to enhance Stryker's footprint ... The company’s portfolio of mechanical thrombectomy devices is set to ‘complement’ Stryker’s neurovascular division.

Surmodics (Nasdaq:SRDX) today announced the successful early clinical use of its Pounce XL thrombectomy system.

Stryker reported goodwill and other impairments of $818 million related to the spine business in the fourth quarter.

Inc. (NARI) has reached a new 52-week high, with its stock price climbing to $79.7, marking a significant milestone for the ...

Akura Medical, Inc., a privately held portfolio company of Shifamed LLC that is developing treatments for venous thromboembolis ...

4. Zimmer Biomet has entered into a definitive agreement to purchase Paragon 28, a medical device company focused exclusively on foot-and-ankle orthopedics.

Inari shareholders are getting a fair price ... stents, and mechanical thrombectomy devices. It’s a business that Stryker has built through a combination of internal R&D and M&A, including ...